Position Statements and other Clinical Recommendations
Advice for GPs and other Health Professionals caring for patients with
Rheumatoid Arthritis, SLE and other autoimmune diseases in the COVID-19 crisis.
Download advice July 21 2021 Edition
Download the THANZ Multidisciplinary VITT Guideline for Doctors
A severe prothrombotic syndrome associated with thrombocytopenia has been described in a small number of patients exposed to the COVID-19 AstraZeneca and Janssen (Johnson & Johnson) vaccine. This syndrome is currently being called several names: VITT (vaccine-induced immune thrombotic syndrome), TTS (thrombosis with thrombocytopenia syndrome), and VIPIT (vaccine-induced prothrombotic immune thrombocytopenia). For the purposes of this Thrombosis & Haemostasis society of Australia New Zealand (THANZ) Multidisciplinary guideline, the term VITT will be used. It has been observed in early reported cases that platelet transfusions and administration of heparin may lead to progressive thrombosis.
- Zoster and Pneumococcal vaccination - click here to download advice July 2020
- Vaccinations in Autoimmune Inflammatory Rheumatic Disease for GPs/AHPs June 2021
- Table of Vaccinations updated June 2021
Arthritis Australia Giant Cell Arteritis Information Sheet
Rheumatoid arthritis: getting the facts straight about methotrexate
Dr Mona Marabani leads an interdisciplinary discussion about why early diagnosis and treatment are crucial for improved health outcomes for people with rheumatoid arthritis, and how good communication and collaborative care can help patients get the most out of methotrexate treatment. For CPD certification, click on the link below.
ARA and Arthritis Australia Statement regarding the use of glucosamine for the treatment of Osteoarthritis
AOA/ARA Position Statement on stem cell therapy.
ARA Position Statement on the introduction of biosimilars for the treatment of rheumatic diseases.
ARA Position Statement on the use of medicinal cannabis for musculoskeletal pain.
Guidelines on Biological Agents and Small Molecule Medications for the Treatment of Rheumatic Diseases
Low Dose Once-weekly Methotrexate Information
Supporting safe practices for low-dose methotrexate: CATAG Position Statement on the use of low-dose methotrexate
Guidance on the Management of low dose Methotrexate in Hospitals and other Health Care Facilities
Guidance on Self-Injecting Methotrexate for the Treatment of Arthritis
Pregnancy Prescribing Information
Medications and Pregnancy- Rheumatoid Arthritis. Information for women and men with rheumatoid arthritis thinking about starting a family.
Prescriber’s information on Medications for Rheumatic Diseases in Pregnancy
Fertility Preservation Guidelines
Osteoarthritis of the Knee
Updated RACGP Guideline for the management of hip and knee osteoarthritis (Second Edition)
Osteoarthritis of the Knee Clinical Care Standard May 2017